Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000283446 identifies a genomic sequence that is a pseudogene related to the meprin A subunit beta (MEP1B) gene. Pseudogenes are typically non-functional genomic relics that have lost their protein-coding ability due to accumulating mutations such as premature stop codons, frameshifts, or deletions. This specific entity refers to such a non-coding, non-functional gene remnant, distinct from the active, protein-coding MEP1B gene. While some pseudogenes may acquire regulatory functions, ENSG00000283446 is primarily recognized as a vestigial gene copy and is not considered an active therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Meprin A subunit beta pseudogene.